
Monthly PrEP pill could be made for US$3 a year, but Latin America is shut out of generic licensing
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNYkpoS3dDM0ZCZzRIUXR6NWp6b3hfZ2hwYVhQSlBTclZUdHpPWkU1OFJxbndVU0poMHo4ZjVjVkRwNzhEa0hOcklOTkluaTdPbERMUTJxR1hlbW9HcXdGaF9jalgtWmRMLThLWXU3VHluQ0lOYUFiQ1JJeGNFVEtZQUhzTENuOXVLTFhhQ1MyZU9telM3RWM2cXZ2WGN2bmdlX05raDZaQ25aYXh4dldoQ0E4emRkdGR5X1BB?oc=5" target="_blank">Monthly PrEP pill could be made for US$3 a year, but Latin America is shut out of generic licensing</a>&nbsp;&nbsp;<font color="#6f6f6f">Aidsmap</font>
